Epidemiologic and laboratory findings from 3 years of testing United States blood donors for Trypanosoma cruzi

Transfusion

Volumn 52, Issue 9, 2012, Pages 1901-1911

  Custer, Brian ^a,b,c,d,e,f   Agapova, Maria ^a,b,c,d,e,f   Bruhn, Roberta ^a,b,c,d,e,f   Cusick, Robin ^a,b,c,d,e,f   Kamel, Hany ^a,b,c,d,e,f   Tomasulo, Peter ^a,b,c,d,e,f   Biswas, Hope ^a,b,c,d,e,f   Tobler, Leslie ^a,b,c,d,e,f   Lee, Tzong Hae ^a,b,c,d,e,f   Caglioti, Sally ^a,b,c,d,e,f   Busch, Michael ^a,b,c,d,e,f  

^a BLOOD SYSTEMS RESEARCH INSTITUTE   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d Blood Systems Incorporated   (United States)

^e UNIVERSITY OF CALIFORNIA   (United States)

^f CREATIVE TESTING SOLUTIONS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; BLOOD DONOR; BLOOD EXAMINATION; BLOOD TRANSFUSION; CHAGAS DISEASE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FOLLOW UP; HUMAN; INFECTION RISK; INTERVIEW; MAJOR CLINICAL STUDY; MALE; MEXICO; POLYMERASE CHAIN REACTION; RADIOIMMUNOPRECIPITATION; REDUVIIDAE; RURAL AREA; SERODIAGNOSIS; SEROPREVALENCE; SOUTH AMERICA; SOUTH AND CENTRAL AMERICA; TRYPANOSOMA CRUZI; UNITED STATES;

ADULT; ANIMALS; BLOOD DONORS; BLOOD TRANSFUSION; CHAGAS DISEASE; CLINICAL LABORATORY TECHNIQUES; FEMALE; FOLLOW-UP STUDIES; HEMATOLOGIC TESTS; HUMANS; INTERVIEWS AS TOPIC; MALE; MIDDLE AGED; SEROEPIDEMIOLOGIC STUDIES; TIME FACTORS; TRYPANOSOMA CRUZI; UNITED STATES; YOUNG ADULT;

EID: 84865761211     PISSN: 00411132     EISSN: 15372995     Source Type: Journal    
DOI: 10.1111/j.1537-2995.2012.03569.x     Document Type: Article

References (45)

1. Marin-Neto JA, Rassi A Jr, Morillo CA, Avezum A, Connolly SJ, Sosa-Estani S, Rosas F, Yusuf S,; BENEFIT Investigators. Rationale and design of a randomized placebo-controlled trial assessing the effects of etiologic treatment in Chagas' cardiomyopathy: the BENznidazole Evaluation For Interrupting Trypanosomiasis (BENEFIT). Am Heart J 2008; 156: 37-43.
2. Laranja FS, Dias E, Miranda A, Nobrega G,. Chagas' disease; a clinical, epidemiologic, and pathologic study. Circulation 1956; 14: 1035-60.
3. Bern C, Montgomery SP, Herwaldt BL, Rassi A Jr, Marin-Neto JA, Dantas RO, Maguire JH, Acquatella H, Morillo C, Kirchhoff LV, Gilman RH, Reyes PA, Salvatella R, Moore AC,. Evaluation and treatment of Chagas disease in the United States: a systematic review. JAMA 2007; 298: 2171-81.
4. Bern C, Montgomery SP, Katz L, Caglioti S, Stramer SL,. Chagas disease and the US blood supply. Curr Opin Infect Dis 2008; 21: 476-82.
5. Coura JR,. Chagas disease: what is known and what is needed-a background article. Mem Inst Oswaldo Cruz 2007; 102 (Suppl 1): 113-22.
6. Schmunis GA,. Epidemiology of Chagas disease in non-endemic countries: the role of international migration. Mem Inst Oswaldo Cruz 2007; 102 (Suppl 1): 75-85.
7. Young C, Losikoff P, Chawla A, Glasser L, Forman E,. Transfusion-acquired Trypanosoma cruzi infection. Transfusion 2007; 47: 540-4.
8. Mascola L, Kubak B, Radhakrishna S, Mone T, Hunter R, Leiby DA, Kuehnert M, Moore A, Steurer F, Lawrence G, Kun H,. Chagas disease after organ transplantation-Los Angeles, California, 2006. MMWR Morb Mortal Wkly Rep 2006; 55: 798-800.
9. Kun H, Moore A, Mascola L, Steurer F, Lawrence G, Kubak B, Radhakrishna S, Leiby D, Herron R, Mone T, Hunter R, Kuehnert M,; Chagas Disease in Transplant Recipients Investigation Team. Transmission of Trypanosoma cruzi by heart transplantation. Clin Infect Dis 2009; 48: 1534-40.
10. Teixeira AR, Nitz N, Guimaro MC, Gomes C, Santos-Buch CA,. Chagas disease. Postgrad Med J 2006; 82: 788-98.
11. Hernandez-Becerril N, Mejia AM, Ballinas-Verdugo MA, Garza-Murillo V, Manilla-Toquero E, Lõpez R, Trevethan S, Cardenas M, Reyes PA, Hirayama K, Monteõn VM,. Blood transfusion and iatrogenic risks in Mexico City. Anti-Trypanosoma cruzi seroprevalence in 43,048 blood donors, evaluation of parasitemia, and electrocardiogram findings in seropositive. Mem Inst Oswaldo Cruz 2005; 100: 111-6.
12. Bern C, Montgomery SP,. An estimate of the burden of Chagas disease in the United States. Clin Infect Dis 2009; 49: e52-4.
13. Leiby DA, Rentas FJ, Nelson KE, Stambolis VA, Ness PM, Parnis C, McAllister HA Jr, Yawn DH, Stumpf RJ, Kirchhoff LV,. Evidence of Trypanosoma cruzi infection (Chagas' disease) among patients undergoing cardiac surgery. Circulation 2000; 102: 2978-82.
14. Diagnostics O-C,. ORTHO®T. cruzi ELISA Test System [Package Insert]. Raritan, NJ, 2009.
15. US Department of Health and Human Services FaDA. NEWS RELEASE-FDA approves first supplemental test for Chagas disease. 2011.
16. Tobler LH, Contestable P, Pitina L, Groth H, Shaffer S, Blackburn GR, Warren H, Lee SR, Busch MP,. Evaluation of a new enzyme-linked immunosorbent assay for detection of Chagas antibody in US blood donors. Transfusion 2007; 47: 90-6.
17. Gorlin J, Rossmann S, Robertson G, Stallone F, Hirschler N, Nguyen KA, Gilcher R, Fernandes H, Alvey S, Ajongwen P, Contestable P, Warren H,. Evaluation of a new Trypanosoma cruzi antibody assay for blood donor screening. Transfusion 2008; 48: 531-40.
18. Kirchhoff LV, Gam AA, Gusmao RA, Goldsmith RS, Rezende JM, Rassi A,. Increased specificity of serodiagnosis of Chagas' disease by detection of antibody to the 72- and 90-kilodalton glycoproteins of Trypanosoma cruzi. J Infect Dis 1987; 155: 561-4.
19. Leiby DA, Wendel S, Takaoka DT, Fachini RM, Oliveira LC, Tibbals MA,. Serologic testing for Trypanosoma cruzi: comparison of radioimmunoprecipitation assay with commercially available indirect immunofluorescence assay, indirect hemagglutination assay, and enzyme-linked immunosorbent assay kits. J Clin Microbiol 2000; 38: 639-42.
20. Winkler MA, Brashear RJ, Hall HJ, Schur JD, Pan AA,. Detection of antibodies to Trypanosoma cruzi among blood donors in the southwestern and western United States. II. Evaluation of a supplemental enzyme immunoassay and radioimmunoprecipitation assay for confirmation of seroreactivity. Transfusion 1995; 35: 219-25.
21. Virreira M, Torrico F, Truyens C, Alonso-Vega C, Solano M, Carlier Y, Svoboda M,. Comparison of polymerase chain Reaction methods for reliable and easy detection of congenital Trypanosoma cruzi infection. Am J Trop Med Hyg 2003; 68: 574-82.
22. American Association of Blood Banks. Chagas' Biovigilance Network. Bethesda (MD): American Association of Blood Banks; 2010.
23. Leiby DA, Herron RM Jr, Read EJ, Lenes BA, Stumpf RJ,. Trypanosoma cruzi in Los Angeles and Miami blood donors: impact of evolving donor demographics on seroprevalence and implications for transfusion transmission. Transfusion 2002; 42: 549-55.
24. Wilson LS, Ramsey JM, Koplowicz YB, Valiente-Banuet L, Motter C, Bertozzi SM, Tobler LH,. Cost-effectiveness of implementation methods for ELISA serology testing of Trypanosoma cruzi in California blood banks. Am J Trop Med Hyg 2008; 79: 53-68.
25. Dorn PL, Yabsley MJ, Roellig DM, Balsamo G, Diaz J, Wesson D,. Autochthonous transmission of Trypanosoma cruzi, Louisiana. Emerg Infect Dis 2007; 13 605-7.
26. Cantey PT, Stramer SL, Kamel H, Currier M, Townsend RL, Winton C, Ofafa K, Steurer FJ, Todd C, Montgomery S,. The U.S. Trypanosoma cruzi infection study: evidence for autochthonous trypanosoma cruzi transmission among United States blood donors. Transfusion 2010; 50: 1.
27. Galel SA, Kirchhoff LV,. Risk factors for Trypanosoma cruzi infection in California blood donors. Transfusion 1996; 36: 227-31.
28. Leiby DA, Read EJ, Lenes BA, Yund AJ, Stumpf RJ, Kirchhoff LV, Dodd RY,. Seroepidemiology of Trypanosoma cruzi, etiologic agent of Chagas' disease, in US blood donors. J Infect Dis 1997; 176: 1047-52.
29. O'Brien SF, Chiavetta JA, Fan W, Xi G, Yi QL, Goldman M, Scalia V, Fearon MA,. Assessment of a travel question to identify donors with risk of Trypanosoma cruzi: operational validity and field testing. Transfusion 2008; 48: 755-61.
30. Schijman AG, Bisio M, Orellana L, Sued M, Duffy T, Mejia Jaramillo AM, Cura C, Auter F, Veron V, Qvarnstrom Y, Deborggraeve S, Hijar G, Zulantay I, Lucero RH, Velazquez E, Tellez T, Sanchez Leon Z, Galvão L, Nolder D, Monje Rumi M, Levi JE, Ramirez JD, Zorrilla P, Flores M, Ladzins J, et al,. International study to evaluate PCR methods for detection of Trypanosoma cruzi DNA in blood samples from Chagas disease patients. PLoS Negl Trop Dis 2011; 5: e931.
31. Galaz P, Garcia S, Mercado R, Orrego E, Pagliero B, Contreras Mdel C, Salinas P, Arancibia C,. [Parasitological and epidemiological aspects of Trypanosoma cruzi seropositive blood donors]. Rev Med Chil 2007; 135: 1291-5.
32. Leiby DA, Herron RM Jr, Garratty G, Herwaldt BL,. Trypanosoma cruzi parasitemia in US blood donors with serologic evidence of infection. J Infect Dis 2008; 198: 609-13.
33. US Food and Drug Administration. Center for Biologics Evaulation and Research. Guidance for industry: use of serological tests to reduce the risk of transmission of Trypanosoma cruzi infection in whole blood and blood components intended for transfusion. 2010. [cited 2012 Feb 6]. Available from: URL: http://www.fda.gov/biologicsbloodvaccines/ guidancecomplianceregulatoryinformation/guidances/blood/ucm235855.htm
34. Stramer SL,. Update on the study to further define the incidence of T. cruzi infection in the U.S. blood donor population. Transcript of Blood Products Advisory Committee meeting: Food and Drug Administration. 2010.
35. Stramer SL, Notari EP, Townsend RL, Custer B, Kamel H, Busch MP, Dodd RY,. No evidence of Trypanosoma cruzi incidence in US blood donors: a 4-year study. Transfusion 2011; 51: 1.
36. US Food and Drug Administration. Center for Biologics Evaulation and Research. 94th Blood Products Advisory Committee Meeting briefing information-potential testing strategies for T. cruzi infection in blood donors. 2009. [cited 2012 Feb 6]. Available from: URL: http://www.fda.gov/downloads/ AdvisoryCommittees/CommitteesMeetingMaterials/BloodVaccinesandOtherBiologics/ BloodProductsAdvisoryCommittee/UCM155628.pdf
37. Kessler D, Grima KM, Hillyer CD,. Chagas transmission identified through lookback. Transfusion 2010; 50: 1.
38. Vanderpool SK, Mocciaro BL, Kamel H, Custer B,. Three year study of T. cruzi: lookback from a large institution. Transfusion 2010; 50: 1.
39. Raether W, Michel R, Uphoff M,. Effects of dimethylsulfoxide and the deep-freezing process on the infectivity, motility, and ultrastructure of Trypanosoma cruzi. Parasitol Res 1988; 74: 307-13.
40. Piron M,. Relevance of parasite infections outside of South and Central America: Chagas disease and malaria. ISBT Science Series 2010; 5: 6.
41. Furucho CR, Umezawa ES, Almeida I, Freitas VL, Bezerra R, Nunes EV, Sanches MC, Guastini CM, Teixeira AR, Shikanai-Yasuda MA,. Inconclusive results in conventional serological screening for Chagas' disease in blood banks: evaluation of cellular and humoral response. Trop Med Int Health 2008; 13: 1527-33.
42. Sabino EC, Salles NA, Sarr M, Barreto AM, Oikawa M, Oliveira CD, Leao SC, Carneiro-Proietti AB, Custer B, Busch MP,; NHLBI Retrovirus Epidemiology Donor Study-II (REDS-II), International Component. Enhanced classification of Chagas serologic results and epidemiologic characteristics of seropositive donors at three large blood centers in Brazil. Transfusion 2010; 50: 2628-37.
43. Remesar MC, Gamba C, Colaianni IF, Puppo M, Sartor PA, Murphy EL, Neilands TB, Ridolfi MA, Leguizamõn MS, Kuperman S, Del Pozo AE,. Estimation of sensitivity and specificity of several Trypanosoma cruzi antibody assays in blood donors in Argentina. Transfusion 2009; 49: 2352-8.
44. Agapova M, Busch MP, Custer B,. Cost-effectiveness of screening the US blood supply for Trypanosoma cruzi. Transfusion 2010; 50: 2220-32.
45. Custer B, Hoch JS,. Cost-effectiveness analysis: what it really means for transfusion medicine decision making. Transfus Med Rev 2009; 23: 1-12.